Homburger advised Santhera Pharmaceuticals Holding on the settlement of its first exchange offer for a convertible bond in Switzerland.
Holders of current Santhera CHF 60 Unsecured Convertible Bonds due in 2022 have received new CHF 30,270,375 Senior Unsecured Convertible Bond due 2024 as well as 26 Santhera shares per existing bond. Holders of 74.4% of the former bonds have accepted the offer.
Homburger acted with a team led by partners Dieter Gericke (pictured) and Daniel Häusermann (both Corporate / M&A, Capital Markets). Key team members included partner Stefan Oesterhelt (Tax), counsel Eduard De Zordi (Financing and Investment Products) and associates Marco Rostetter and Romain Fakhoury (both Corporate / M&A, Capital Markets), along with Pierina Janett-Seiler and Daniel Junginger (both Financing and Investment Products) and junior associate Daniel Bötticher.